Androgen deprivation therapy and fracture: the risk dispelled?

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1343, 2011-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased fracture risk with androgen-deprivation therapy

By  

Reactions Weekly, Vol. 1, Iss. 1035, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Menopausal hormone therapy: lower fracture risk, but at a cost?

By  

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Psychotropic medications: increased risk of fracture?

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite

Reduced risk of macular degeneration with statin therapy?

By  

Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite